Proton Magnetic Resonance Spectroscopy in Multiple Sclerosis

Balasrinivasa R. Sajja, Jerry S. Wolinsky, Ponnada A. Narayana

Research output: Contribution to journalReview article

78 Citations (Scopus)

Abstract

Proton magnetic resonance spectroscopy (1H-MRS) provides tissue metabolic information in vivo. This article reviews the role of MRS-determined metabolic alterations in lesions, normal-appearing white matter, gray matter, and spinal cord in advancing our knowledge of pathologic changes in multiple sclerosis (MS). In addition, the role of MRS in objectively evaluating therapeutic efficacy is reviewed. This potential metabolic information makes MRS a unique tool to follow MS disease evolution, understand its pathogenesis, evaluate the disease severity, establish a prognosis, and objectively evaluate the efficacy of therapeutic interventions.

Original languageEnglish (US)
Pages (from-to)45-58
Number of pages14
JournalNeuroimaging Clinics of North America
Volume19
Issue number1
DOIs
StatePublished - Feb 1 2009

Fingerprint

Multiple Sclerosis
Spinal Cord
Therapeutics
Proton Magnetic Resonance Spectroscopy
Gray Matter
White Matter

Keywords

  • Brain metabolites
  • Multiple sclerosis
  • Proton magnetic resonance spectroscopy

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Clinical Neurology

Cite this

Proton Magnetic Resonance Spectroscopy in Multiple Sclerosis. / Sajja, Balasrinivasa R.; Wolinsky, Jerry S.; Narayana, Ponnada A.

In: Neuroimaging Clinics of North America, Vol. 19, No. 1, 01.02.2009, p. 45-58.

Research output: Contribution to journalReview article

Sajja, Balasrinivasa R. ; Wolinsky, Jerry S. ; Narayana, Ponnada A. / Proton Magnetic Resonance Spectroscopy in Multiple Sclerosis. In: Neuroimaging Clinics of North America. 2009 ; Vol. 19, No. 1. pp. 45-58.
@article{a204196caf604027942833230413f749,
title = "Proton Magnetic Resonance Spectroscopy in Multiple Sclerosis",
abstract = "Proton magnetic resonance spectroscopy (1H-MRS) provides tissue metabolic information in vivo. This article reviews the role of MRS-determined metabolic alterations in lesions, normal-appearing white matter, gray matter, and spinal cord in advancing our knowledge of pathologic changes in multiple sclerosis (MS). In addition, the role of MRS in objectively evaluating therapeutic efficacy is reviewed. This potential metabolic information makes MRS a unique tool to follow MS disease evolution, understand its pathogenesis, evaluate the disease severity, establish a prognosis, and objectively evaluate the efficacy of therapeutic interventions.",
keywords = "Brain metabolites, Multiple sclerosis, Proton magnetic resonance spectroscopy",
author = "Sajja, {Balasrinivasa R.} and Wolinsky, {Jerry S.} and Narayana, {Ponnada A.}",
year = "2009",
month = "2",
day = "1",
doi = "10.1016/j.nic.2008.08.002",
language = "English (US)",
volume = "19",
pages = "45--58",
journal = "Neuroimaging Clinics of North America",
issn = "1052-5149",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Proton Magnetic Resonance Spectroscopy in Multiple Sclerosis

AU - Sajja, Balasrinivasa R.

AU - Wolinsky, Jerry S.

AU - Narayana, Ponnada A.

PY - 2009/2/1

Y1 - 2009/2/1

N2 - Proton magnetic resonance spectroscopy (1H-MRS) provides tissue metabolic information in vivo. This article reviews the role of MRS-determined metabolic alterations in lesions, normal-appearing white matter, gray matter, and spinal cord in advancing our knowledge of pathologic changes in multiple sclerosis (MS). In addition, the role of MRS in objectively evaluating therapeutic efficacy is reviewed. This potential metabolic information makes MRS a unique tool to follow MS disease evolution, understand its pathogenesis, evaluate the disease severity, establish a prognosis, and objectively evaluate the efficacy of therapeutic interventions.

AB - Proton magnetic resonance spectroscopy (1H-MRS) provides tissue metabolic information in vivo. This article reviews the role of MRS-determined metabolic alterations in lesions, normal-appearing white matter, gray matter, and spinal cord in advancing our knowledge of pathologic changes in multiple sclerosis (MS). In addition, the role of MRS in objectively evaluating therapeutic efficacy is reviewed. This potential metabolic information makes MRS a unique tool to follow MS disease evolution, understand its pathogenesis, evaluate the disease severity, establish a prognosis, and objectively evaluate the efficacy of therapeutic interventions.

KW - Brain metabolites

KW - Multiple sclerosis

KW - Proton magnetic resonance spectroscopy

UR - http://www.scopus.com/inward/record.url?scp=57049160388&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=57049160388&partnerID=8YFLogxK

U2 - 10.1016/j.nic.2008.08.002

DO - 10.1016/j.nic.2008.08.002

M3 - Review article

C2 - 19064199

AN - SCOPUS:57049160388

VL - 19

SP - 45

EP - 58

JO - Neuroimaging Clinics of North America

JF - Neuroimaging Clinics of North America

SN - 1052-5149

IS - 1

ER -